missing translation for 'onlineSavingsMsg'
Learn More
Learn More
LDLR Antibody (C7) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-80833
This item is not returnable.
View return policy
Description
LDLR Monoclonal specifically detects LDLR in Human, Rat, Porcine, Bovine samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, In vitro assay, Radioimmunoassay, Electron Microscopy.
Specifications
| LDLR | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot : 1:1000, Flow Cytometry reported in scientific literature (PMID 10906332), ELISA, Immunohistochemistry : 1:200, Immunocytochemistry/Immunofluorescence : 1:100, Immunoprecipitation 1:10 - 1:500, Immunohistochemistry-Paraffin : 1:200, Immunohistochemistry-Frozen reported in scientific literature (PMID 11839845), In vitro assay reported in scientific literature (PMID 9642270), Radioimmunoassay, Electron Microscopy reported in scientific literature (PMID 11839845) | |
| FH, FHC, LDL receptor, LDLCQ2, low density lipoprotein receptor, low-density lipoprotein receptor, low-density lipoprotein receptor class A domain-containing protein 3 | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| Human, Rat, Pig, Bovine | |
| Purified |
| Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
| C7 | |
| Unconjugated | |
| Tris-Glycine, 0.15M NaCl | |
| LDLR | |
| Partially purified bovine LDL receptor [Swiss-Prot# P01131]. | |
| 0.1 mL | |
| Cancer, Cholesterol Metabolism, Lipid and Metabolism, Signal Transduction | |
| 3949 | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
| IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction